HERTART ApS: Financial statements 2023
CVR: 32840787
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
HERTART ApS (CVR 32840787) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 1,875,975 and a net result of DKK 1,596,417 compared with DKK 3,356,076 the year before. That is a decrease of 56.3% compared with the year before. Equity in the 2023 report amounted to DKK 5,189,002. The solvency ratio was 74.2%.
- Gross Profit
- DKK 1,875,975
- Profit/Loss
- DKK 1,596,417
- Equity
- DKK 5,189,002
- Total Assets
- DKK 6,995,356
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 1.9 mio. | 1.6 mio. | 5.2 mio. | - |
| 2022 | - | 4.3 mio. | 3.4 mio. | 3.6 mio. | - |
| 2021 | - | 2.3 mio. | 1.8 mio. | 8 mio. | - |
| 2020 | - | 1 mio. | 1.1 mio. | 6.3 mio. | - |
| 2019 | - | 876 t. | 870 t. | 5.1 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
HERTART ApS has published its annual report for 2022. Gross profit came to DKK 4,292,959, and the net result was DKK 3,356,076.
About HERTART ApS
HERTART ApS is a Danish company of the type Anpartsselskab based in Greve, founded in 2010. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Per Svensson. The board consists of Per Svensson, Ralf Piegsa and Tom Faes. The company is owned by Vitrolife AB. The company has 0 employees (2012). In 2025, the company reported a gross profit of DKK 3,212,963 and a net result of DKK 2,675,487 compared with DKK 3,485,182 the year before. Equity in the 2025 report amounted to DKK 11,349,671.